Classification

Modern Applications of Bioequivalence & Bioavailability is committed to publish original research in all aspects of areas of Bioequivalence and Bioavailability through rapid peer-review process. MABB aims to promote more information about Bioequivalence and Bioavailability and its related science to enhance the exchange of scientific knowledge among peers. Juniper strongly welcomes researchers for submission of papers in different formats like original research papers, review articles, News, short communications, Opinions, letter to editors on a breadth of topics related to Regulatory Requirements in Bioequivalence, Biosimilars, Advances in Bioavailability, FDA Bioequivalence, Absolute bioavailability, Biowaivers, Clinical pharmacy, Toxicology, Biosimilars, Bioaccessibility, and other interesting topics related to Bioequivalence and Bioavailability.

Contact us at : mabb@juniperpublishers.com
mabb@juniperpublishers.org
mabb@juniperpublisher.org
mabb@juniperpublishers.co
mabb@juniperjournals.org

Classification:

  • Advances in Bioavailability
  • Anvisa Bioequivalence
  • BA/BE Studies
  • Bioequivalence Anticancers
  • Bioequivalence Antidiabetics
  • Bioequivalence Antidiuretics
  • Bioequivalence Antipsychotics
  • Bioequivalence Cardiovascular Products
  • Bioequivalence Study Design
  • Bioequivalence Study Protocols
  • Biosimilars
  • Clinical Cancer Trials
  • Clinical Drug Trial
  • European Bioequivalence
  • Experimental Drug Trial
  • FDA Bioequivalence
  • In vitro Bioequivalence
  • Paid Clinical Trials
  • Regulatory Requirements in Bioequivalence